Laura Benjamin

Laura E. Benjamin is a seasoned leader in the biopharmaceutical and academic sectors, currently serving as the CEO and President of BioHybrid Solutions since September 2023, where the focus is on developing novel technologies for biologics. Previously, Laura was the CEO and President of OncXerna Therapeutics from January 2018 to August 2023, dedicated to advancing oncology therapeutics. Laura's extensive experience includes a tenure as Senior Editor for Cancer Research at the American Association for Cancer Research and Vice President of Oncology at Eli Lilly and Company, where strategic management spanned drug and biomarker discovery, clinical programming, and portfolio management. Additionally, Laura held academic positions at Harvard Medical School, contributing to cancer biology research and supervising students and junior faculty. Laura's educational background includes a PhD in Molecular Biology of Cancer from the University of Pennsylvania and a BA in Biology from Barnard College, Columbia University.